Literature DB >> 28978986

The relationship between obesity and hypertension: an updated comprehensive overview on vicious twins.

Massimo Leggio1, Mario Lombardi2, Elisa Caldarone2, Paolo Severi1,2, Stefania D'Emidio2, Massimo Armeni3, Veronica Bravi4, Maria Grazia Bendini5, Andrea Mazza5.   

Abstract

Obesity is a growing global health concern, with a rapid increase being observed in morbid obesity. Obesity is associated with an increased cardiovascular risk and earlier onset of cardiovascular morbidity. The growing obesity epidemic is a major source of unsustainable health costs and morbidity and mortality because of hypertension, type 2 diabetes mellitus, dyslipidemia, certain cancers and major cardiovascular diseases. Similar to obesity, hypertension is a key unfavorable health metric that has disastrous health implications: currently, hypertension is the leading contributor to global disease burden, and the direct and indirect costs of treating hypertension are exponentially higher. Poor lifestyle characteristics and health metrics often cluster together to create complex and difficult-to-treat phenotypes: excess body mass is such an example, facilitating a cascade of pathophysiological sequelae that create such as a direct obesity-hypertension link, which consequently increases cardiovascular risk. Although some significant issues regarding assessment/management of obesity remain to be addressed and the underlying mechanisms governing these disparate effects of obesity on cardiovascular disease are complex and not completely understood, a variety of factors could have a critical role. Consequently, a comprehensive and exhaustive investigation of this relationship should analyze the pathogenetic factors and pathophysiological mechanisms linking obesity to hypertension as they provide the basis for a rational therapeutic strategy in the aim to fully describe and understand the obesity-hypertension link and discuss strategies to address the potential negative consequences from the perspective of both primordial prevention and treatment for those already impacted by this condition.

Entities:  

Mesh:

Year:  2017        PMID: 28978986     DOI: 10.1038/hr.2017.75

Source DB:  PubMed          Journal:  Hypertens Res        ISSN: 0916-9636            Impact factor:   3.872


  260 in total

1.  Sleep as a mediator of the relationship between socioeconomic status and health: a hypothesis.

Authors:  E Van Cauter; K Spiegel
Journal:  Ann N Y Acad Sci       Date:  1999       Impact factor: 5.691

2.  Type 2 diabetes as a "coronary heart disease equivalent": an 18-year prospective population-based study in Finnish subjects.

Authors:  Auni Juutilainen; Seppo Lehto; Tapani Rönnemaa; Kalevi Pyörälä; Markku Laakso
Journal:  Diabetes Care       Date:  2005-12       Impact factor: 19.112

3.  Results of the Diet, Exercise, and Weight Loss Intervention Trial (DEW-IT).

Authors:  Edgar R Miller; Thomas P Erlinger; Deborah R Young; Megan Jehn; Jeanne Charleston; Donna Rhodes; Sharmeel K Wasan; Lawrence J Appel
Journal:  Hypertension       Date:  2002-11       Impact factor: 10.190

4.  The metabolic significance of leptin in humans: gender-based differences in relationship to adiposity, insulin sensitivity, and energy expenditure.

Authors:  A Kennedy; T W Gettys; P Watson; P Wallace; E Ganaway; Q Pan; W T Garvey
Journal:  J Clin Endocrinol Metab       Date:  1997-04       Impact factor: 5.958

5.  Obesity and the risk of myocardial infarction in 27,000 participants from 52 countries: a case-control study.

Authors:  Salim Yusuf; Steven Hawken; Stephanie Ounpuu; Leonelo Bautista; Maria Grazia Franzosi; Patrick Commerford; Chim C Lang; Zvonko Rumboldt; Churchill L Onen; Liu Lisheng; Supachai Tanomsup; Paul Wangai; Fahad Razak; Arya M Sharma; Sonia S Anand
Journal:  Lancet       Date:  2005-11-05       Impact factor: 79.321

6.  Prevention of metabolic disorders with telmisartan and indapamide in a Chinese population with high-normal blood pressure.

Authors:  Jie Peng; Yingxin Zhao; Hua Zhang; Zhendong Liu; Zhihao Wang; Mengxiong Tang; Ming Zhong; Fanghong Lu; Wei Zhang
Journal:  Hypertens Res       Date:  2014-10-02       Impact factor: 3.872

Review 7.  Dietary approaches to the treatment of obesity.

Authors:  Angela Makris; Gary D Foster
Journal:  Psychiatr Clin North Am       Date:  2011-12

8.  Dissociation of sympathoexcitatory and vasodilator actions of modestly elevated plasma insulin levels.

Authors:  M Hausberg; A L Mark; R P Hoffman; C A Sinkey; E A Anderson
Journal:  J Hypertens       Date:  1995-09       Impact factor: 4.844

Review 9.  The role of obesity and obstructive sleep apnea in the pathogenesis and treatment of resistant hypertension.

Authors:  Jonathan A Marcus; Aravind Pothineni; Carolina Z Marcus; John D Bisognano
Journal:  Curr Hypertens Rep       Date:  2014-01       Impact factor: 5.369

Review 10.  Exercise for overweight or obesity.

Authors:  K Shaw; H Gennat; P O'Rourke; C Del Mar
Journal:  Cochrane Database Syst Rev       Date:  2006-10-18
View more
  45 in total

Review 1.  Cardiovascular Diseases in Obesity: What is the Role of Magnesium?

Authors:  Loanne Rocha Dos Santos; Stéfany Rodrigues de Sousa Melo; Juliana Soares Severo; Jennifer Beatriz Silva Morais; Lyandra Dias da Silva; Mickael de Paiva Sousa; Thayanne Gabryelle Visgueira de Sousa; Gilberto Simeone Henriques; Dilina do Nascimento Marreiro
Journal:  Biol Trace Elem Res       Date:  2021-01-03       Impact factor: 3.738

Review 2.  Hypertension in Premenopausal and Postmenopausal Women.

Authors:  Yasmin Brahmbhatt; Maitreyee Gupta; Seyed Hamrahian
Journal:  Curr Hypertens Rep       Date:  2019-08-26       Impact factor: 5.369

3.  Effects of high-fat diet on sympathetic neurotransmission in mesenteric arteries from Dahl salt-sensitive rat.

Authors:  Kibrom M Alula; Rebecca Biltz; Hui Xu; Hannah Garver; Erinn L Laimon-Thomson; Gregory D Fink; James J Galligan
Journal:  Auton Neurosci       Date:  2019-10-31       Impact factor: 3.145

4.  Haploinsufficiency of ARHGAP42 is associated with hypertension.

Authors:  Amanda S Fjorder; Malene B Rasmussen; Mana M Mehrjouy; Lusine Nazaryan-Petersen; Claus Hansen; Mads Bak; Niels Grarup; Anne Nørremølle; Lars A Larsen; Henrik Vestergaard; Torben Hansen; Niels Tommerup; Iben Bache
Journal:  Eur J Hum Genet       Date:  2019-03-21       Impact factor: 4.246

Review 5.  Understanding Obesity-Related High Output Heart Failure and Its Implications.

Authors:  Qiuhua Shen; John B Hiebert; Faith K Rahman; Kathryn J Krueger; Bhanu Gupta; Janet D Pierce
Journal:  Int J Heart Fail       Date:  2021-01-13

6.  Hypertension is associated with a variant in the RARRES2 gene in populations of Ouro Preto, Minas Gerais, Brazil: a cross-sectional study.

Authors:  Aline Priscila Batista; Keila Furbino Barbosa; Rafael Júnior de Azevedo; Valeska Natiely Vianna; Erica Maria de Queiroz; Carolina Coimbra Marinho; George Luiz Lins Machado-Coelho
Journal:  Int J Mol Epidemiol Genet       Date:  2021-06-15

7.  Role of connecting tubule glomerular feedback in obesity related renal damage.

Authors:  Sumit R Monu; Mani Maheshwari; Edward L Peterson; Oscar A Carretero
Journal:  Am J Physiol Renal Physiol       Date:  2018-10-10

8.  The prevalence of underweight and overweight/obesity and its correlates among adults in Laos: a cross-sectional national population-based survey, 2013.

Authors:  Supa Pengpid; Manithong Vonglokham; Sengchanh Kounnavong; Vanphanom Sychareun; Karl Peltzer
Journal:  Eat Weight Disord       Date:  2018-09-17       Impact factor: 4.652

Review 9.  Adipose Tissue and Modulation of Hypertension.

Authors:  Eashita Das; Joon Ho Moon; Ju Hee Lee; Nikita Thakkar; Zdenka Pausova; Hoon-Ki Sung
Journal:  Curr Hypertens Rep       Date:  2018-09-18       Impact factor: 5.369

Review 10.  Improving obesity and blood pressure.

Authors:  Masami Tanaka
Journal:  Hypertens Res       Date:  2019-10-25       Impact factor: 3.872

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.